John Camm

Jan 16, 2025 | heart.bmj.com | Zainab Abdali |Karina V. Bunting |Samir Mehta |John Camm

MethodsThe clinical trial design, protocol and outcomes have previously been published.4 8 In brief, RATE-AF was a pragmatic, NHS-embedded, open-label, blinded, endpoint RCT in patients with permanent AF and symptoms of heart failure in need of heart rate control. All participants provided written informed consent after review of participant information material created by the PPI team.

Jun 7, 2023 | medscape.com | John Camm |Jeff S. Healey |Emma Svennberg

closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log outCancel Over the past several decades, increases in global life expectancy and improvements in diagnostic tools have contributed to an increased incidence and prevalence of atrial fibrillation (AF).